Skip to main content

News and Media

Open Main MenuClose Main Menu
2022 Niblack Research Scholars

Six College of Arts and Sciences students named Niblack Scholars

Tuesday, November 15, 2022

Media Contact: Elizabeth Gosney | CAS Marketing and Communications Manager | 405-744-7497 |

Oklahoma State University has named six students from the College of Arts and Sciences as Niblack Research Scholars for 2022-23. These undergraduate students were chosen to conduct mentored research in their given scientific area. 

The selected CAS students are:  

Kaitlyn Cotton, Microbiology, The Colony, Texas

Mary Erdmann, Microbiology, Tulsa

Rabeca Richardson, Integrative Biology, Yukon, Oklahoma

Sarah Teeman, Microbiology, Stillwater

Charlie Vermeire, Microbiology/Cell and Molecular Biology and Biochemistry, Miles City, Montana

Rebecca Wilson, Microbiology, Cave Springs, Arkansas

Each year, the OSU Office of the Vice President for Research facilitates the Niblack Research Scholars (NRS) program. 

The NRS program is made possible by the funding of OSU alumnus Dr. John Niblack. Thanks to Niblack’s generosity, selected students can take part in invaluable research experiences that later assist in career path decisions and future successes.  


About Dr. Niblack  

John Niblack retired in 2002 as Vice Chairman of Pfizer Inc., a $32 billion pharmaceutical company that discovers, develops, manufactures and markets leading prescription medicines for humans and animals and many of the world’s best-known consumer brands. As Vice Chairman, Dr. Niblack was responsible for Pfizer’s Global Research and Development Division and pharmaceutical Licensing and Development. As an active scientist from 1967-1980, Niblack rose in the company through a succession of positions in which he directed research into drugs for viral illnesses, cancer and autoimmune disorders. In 1980, he was appointed director of research for the company’s U.S. laboratories. In 1990, he was named president of Pfizer's Central Research Division and in 1993 was promoted to executive VP of Pfizer Inc. He has a Bachelor of Science in chemistry from OSU and a Ph.D. in biochemistry from the University of Illinois. 

Story By: Kalynn Schwandt, CAS graduate assistant |

Back To Top
SVG directory not found.